Castle biosciences to acquire altheadx

Friendswood, texas--(business wire)---- $cstl #ma--castle biosciences, inc. (nasdaq: cstl), a company improving health through innovative tests that guide patient care, today announced it has signed a definitive agreement to acquire altheadx, inc. (altheadx). altheadx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (pgx) testing services that are focused on mental health. idgenetix® is its pgx test for depression, anxiety and other mental health conditions. “
CSTL Ratings Summary
CSTL Quant Ranking